DNA photo
  Children's Hospital Research  Children's Hospital Labs
Pediatric GI/Nutrition Fellowship  Children's logo  Harvard logo
 Home
 X  X
Bruce E. Sands, MD, SM
Associate Professor of Medicine, Harvard Medical School
Co-Director, Inflammatory Bowel Disease Center, Massachusetts General Hospital
Gastroenterology Associates
55 Fruit Street, BLK 4
Boston, MA 02114-2696
Phone: 617-724-6005
Email: bsands@partners.org
Research Interests

Dr. Sand's interests are in clinical trials of novel therapeutic agents and modalities for Crohn's disease and ulcerative colitis; genotype-phenotype correlations in IBD; validation of disease/treatment outcomes in IBD; prognostic factors in the clinical course of Crohn's disease; pharmacoepidemiology

Selected Publications

Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462-76.

Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128(4):862-9.

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9):876-85.
 X  X